BioAge Labs, Inc.
BIOAPublic
Human-longevity-data-derived metabolic aging therapeutics
Markets
Where the science meets the market
LONGEFI combines advanced AI, proprietary algorithms and expert analysis to map scientific developments to the companies, technologies and market activity they may influence. We do not rate securities, forecast prices or make recommendations.
Listed longevity companies
Tracked for scientific relevance only. No market-data provider is connected.
ChromaDex
CDXCPublic
Nicotinamide riboside (consumer NAD+)
Insilico Medicine
3696.HKPublic
Generative AI drug discovery
Genflow Biosciences
GENFPublic
SIRT6 gene therapy (AAV)
Enlivex Therapeutics Ltd.
ENLVPublic
Allogeneic macrophage-reprogramming cell therapy
Biogen Inc.
BIIBPublic
Antisense oligonucleotide (ASO)
Ionis Pharmaceuticals, Inc.
IONSPublic
Antisense oligonucleotide (ASO)
Denali Therapeutics Inc.
DNLIPublic
Oligonucleotide Transport Vehicle (OTV), blood-brain barrier delivery
Intellia Therapeutics
NTLAPublic
In vivo CRISPR gene editing
Beam Therapeutics
BEAMPublic
Base editing
Recursion Pharmaceuticals
RXRXPublic
Phenomics + ML drug discovery
Lineage Cell Therapeutics, Inc.
LCTXPublic
Allogeneic cell transplant therapies from pluripotent lines
Listing here reflects scientific relevance only. It is not a recommendation, rating or solicitation to trade.
Funding & deals
Published LONGEFI developments classified as funding or deals, newest first.
No funding or deal developments published yet.
Relevant developments will appear here as they enter the LONGEFI intelligence feed.